Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


Susana Banerjee

The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London

United Kingdom

Dr Susana Banerjee (MBBS MA PhD FRCP) is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at the Royal Marsden, London, UK. She is a Team Leader (Honorary Faculty) at the Institute of Cancer Research. Dr Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers.

Dr. Banerjee graduated with a 1st class from St. John's College, University of Cambridge, completed her medical training in 2000 and was a University of London Gold Medal Finalist. She was awarded an Avon Breast Cancer Crusade Clinical Fellowship for laboratory research and gained a PhD from the Institute of Cancer Research, University of London. Dr Banerjee was awarded the San Antonio Breast Cancer Symposium Novartis Oncology Basic Science Award for her research in 2007. Other prizes include the Association of Cancer Physicians McElwain Prize and the Sir Antony Driver Prize. She was also 'highly commended' for the Pfizer British Oncology Association Young Investigator Award. She completed specialist training at The Royal Marsden and appointed a Consultant in 2011. She is a Fellow of the Royal College of Physicians, London.

Dr Susana Banerjee is an active member of the European Society for Medical Oncology (ESMO).  Her contribution to ESMO began by serving on the Young Oncologists Committee (YOC) (2010-2016). She was the Young Oncologists Track Chair of the European Cancer Congress in 2015.  She initiated and led the ESMO YOC Burnout Survey- the largest project on burnout in under 40 year old oncologists (Annals of Oncology). Dr Banerjee was also a Flims (ECCO-AACR-EORTC-ESMO Workshop) Alumni Club Steering Committee member (2010-2011). She was part of the ESMO Nominating Committee in 2014-2015 and is a member of the Women for Oncology Committee (2015-present). Dr Banerjee is the first author of the paper reporting gender-related challenges facing oncologists identified in the ESMO Women for Oncology Committee survey (ESMO Open). Susana has been involved in a number of ESMO-related educational activities including being Co-Chair of the ESMO Medical Students Course (2015, 2016) and an author of the ESMO/ASCO Global Curriculum in Medical Oncology. Dr Banerjee was selected to be part of the first group of rising oncologists to enter the ESMO Leaders Generation Programme (2016) and has subsequently served as faculty in the programme. She is part of the Gynaecological Cancers sub-committee for the ESMO Congress 2017 (in partnership with EACR), 2019 and 2020. She was Track Chair for Gynaecological Cancers for the ESMO Congress 2018. She is committed to the global efforts of ESMO and has been part of the faculty lecturing at the ESMO Summit Middle East (2018) and ESMO Summit Latin America (2019). She was the Scientific Co-Chair for ESMO Asia 2018.

Dr Banerjee was previously ESMO Director of Membership, serving on the ESMO Executive Board and ESMO Council (2020-2022). Her latest ESMO initiative was the development of the ESMO Resilience Task Force aimed at supporting oncologists tackle burnout.

Dr Banerjee has been involved in several national and international specialist groups including the National Cancer Research Institute (NCRI) Gynaecological Cancers Clinical Studies Group (2014-2018), European Organization for Research and Treatment of Cancer (EORTC) Executive Steering Committee for Gynaecological Cancers (2014-2016). Dr Banerjee is an author of over 100 peer-reviewed publications (including New England Journal of Medicine, Lancet Oncology, Nature Communications) and is actively involved in clinical trials and translational research. She has led and been co-applicant of successful grant applications. Her research interests include individualisation of patient treatment and targeted therapies in gynaecological cancers. Dr Banerjee is Chief Investigator (global/national) and principal investigator at the Royal Marsden for multiple clinical trials.

Last update: January 2023

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.